Subscribe to MDT Magazine News

Hotspur Technologiesâ?? IQCath Catheter Receives CE Mark

May 6, 2011 11:44 am | by Bio-Medicine.Org | Comments

MOUNTAIN VIEW, Calif., May 6, 2011 /- Hotspur Technologies, Inc. announced today that it has received CE Mark approval for the IQCath Balloon Dilatation Catheter, allowing the company to introduce the novel technology to markets outside of the United States.  The IQCath catheter...


Acton Pharma names Newman, Phair as new execs

May 6, 2011 11:38 am | by Mass High Tech: The Journal of New England Technology | Comments

Acton Pharmaceuticals Inc., a respiratory therapeutics firm in Marlborough, has appointed two new executives in naming Kenneth Newman as executive vice president, chief medical officer, and Thomas Phair as senior vice president, chief financial officer.


Consumer Information on: St. Jude Medical & #xae; Trifecta? Valve - P100029

May 6, 2011 10:56 am | by U.S. Food & Drug Administration | Comments

The Trifecta valve is a three-leaflet stented pericardial valve designed for supra-annular placement in the aortic position.


Consumer Information on: NovoTTF-100A System - P100034

May 6, 2011 10:53 am | by U.S. Food & Drug Administration | Comments

The NovoTTF-100A System treats recurrent glioblastoma multiforme (GBM).

New Device to Support Blood Circulation for Heart Patients Shows Improved Outcomes Compared to Current Treatment

May 6, 2011 9:45 am | by Bio-Medicine.Org | Comments

BALTIMORE, May 6, 2011 /- A new device designed to assist blood circulation and support blood pressure in high-risk patients undergoing percutaneous coronary intervention (PCI) has shown improved outcomes compared to the standard treatment with an intraaortic balloon pump. Results of the...


FDA Expands Approved Use For Carotid Stent

May 6, 2011 9:45 am | by Bio-Medicine.Org | Comments

SILVER SPRING, Md., May 6, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved an expanded indication that will allow a new group of patients at risk of stroke due to clogged neck arteries to be treated with the RX Acculink carotid stent. (Logo:...


Sequenom rises on Down syndrome test progress

May 6, 2011 9:45 am | by The Associated Press | Comments

Shares of Sequenom Inc. jumped Friday after the diagnostic test maker said it completed testing samples from a clinical study of its SensiGene fetal Down syndrome test.The San Diego company said it will announce results from the study when they are submitted and published in a peer-reviewed...

STMicroelectronics offers the world?s smallest and most accurate location-placing solution

May 6, 2011 8:50 am | by I-Micronews | Comments

Ten-Degrees-of-Freedom sensor set gives precise directions from any place on Earth.


Pentagonal tiles pave the way towards organic electronics

May 6, 2011 8:50 am | by I-Micronews | Comments

New research paves way for the nanoscale self-assembly of organic building blocks, a promising new route towards the next generation of ultra-small electronic devices.

Weck Hem-o-Lok Ligating Clips: Contraindicated for Ligation of Renal Artery During Laparoscopic Living-Donor Nephrectomy

May 6, 2011 8:47 am | by U.S. Food & Drug Administration | Comments

Clips may become dislodged, which can lead to uncontrolled bleeding, additional surgery, or death of the donor.

WellCare 1Q earnings soar on Medicaid Part D gains

May 6, 2011 8:46 am | by The Associated Press | Comments

WellCare Health Plans Inc. said Friday its first-quarter earnings more than tripled as the government health insurance provider saw a big membership gain in Medicare prescription drug plans compared to last year, when enrollment fell mainly due to marketing sanctions from the federal...

FDA Approves New Treatment for Rare Type of Pancreatic Cancer

May 6, 2011 7:54 am | by Bio-Medicine.Org | Comments

SILVER SPRING, Md., May 6, 2011 /PRNewswire-USNewswire/ -- On Thursday, the U.S. Food and Drug Administration approved Afinitor (everolimus) to treat patients with progressive neuroendocrine tumors located in the pancreas (PNET) that cannot be removed by surgery or that have spread to...


Sirona Dental fiscal 2Q profit grows 67 percent

May 6, 2011 7:45 am | by The Associated Press | Comments

Sirona Dental Systems Inc. said Friday its fiscal second-quarter earnings climbed 67 percent, boosted by revenue growth from several segments and strong overseas sales.The Long Island City, N.Y., company earned $29.3 million, or 51 cents per share, in the quarter that ended March 31. That...

Halozyme 1Q profit narrows on revenue boost

May 6, 2011 7:45 am | by The Associated Press | Comments

Biotechnology company Halozyme Therapeutics Inc. on Friday reported a narrowed first-quarter loss on rising revenue from collaborations.The developer of enzyme-based products said it lost $9.6 million, or 10 cents per share, compared with a loss of $11.8 million, or 13 cents per share, during...

AGA presents cutting-edge research during DDW

May 6, 2011 6:47 am | by EurekAlert | Comments

(American Gastroenterological Association) Clinicians, researchers and scientists from around the world will gather for Digestive Disease Week 2011, the largest and most prestigious gastroenterology meeting, from May 7-10, 2011, at McCormick Place, Chicago, Ill. AGA researchers...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.